Clinical Scorecard: Clinical and Refractive Results After Bilateral Enhanced Monofocal IOL Implantation Using Targeted Mini-Monovision
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Clinical and Refractive Results After Bilateral Enhanced Monofocal IOL Implantation Using Targeted Mini-Monovision
Key Mechanisms
Mechanisms or clinical associations described in the source article.
Target Population
Patients included in the source article's study population.
Care Setting
Retrospective observational study of 25 patients (50 eyes) treated at the Department of Ophthalmology, Dokuz Eylül University Faculty of Medicine.
Key Highlights
The study reviewed 25 consecutive patients (50 eyes) treated between December 2022 and April 2024.
All patients received bilateral RayOne EMV implantation using the planned mild mini-monovision protocol.
The dominant eye was targeted for emmetropia and the non-dominant eye for approximately −0.50 D.
Month 6 outcome data were complete for the entire cohort, with no exclusions or loss to follow-up reported.
The supplied excerpt does not provide study outcome results.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
The study reports complete Month 6 outcome data for all 25 patients; the supplied excerpt does not specify the outcome measures or monitoring schedule.
Risks
Eligibility excluded eyes with corneal astigmatism greater than 1.00 D, corneal dystrophy, pseudoexfoliation, zonular weakness, retinal disease, or previous ocular surgery.
Included eyes had axial lengths of 21.74–24.54 mm; the study cohort did not include eyes with extreme axial lengths.
Patient & Prescribing Data
Twenty-five consecutive patients undergoing bilateral cataract surgery; eligibility required RayOne EMV implantation, IOL power of +10.0 to +30.0 D, corneal astigmatism of 1.00 D or less, and no ocular pathology apart from cataract.
All patients received bilateral RayOne EMV IOLs with planned mild mini-monovision: emmetropia in the dominant eye and approximately −0.50 D in the non-dominant eye.
Clinical Best Practices
The study assessed ocular dominance using the hole-in-the-card test before applying its eye-specific refractive targets.
The study's preoperative evaluation included manifest refraction, keratometry, slit-lamp examination, Goldmann applanation tonometry, dilated fundus examination, optical coherence tomography, and optical biometry.
The study included patients meeting its eligibility criteria; its findings cannot be generalized from the supplied excerpt to excluded groups.
